You are here

Article Text

Article menu
Download PDFPDF
Commentary
Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?

https://doi.org/10.1136/gutjnl-2013-304564

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding This work was supported by the agreement between FIMA and the ‘UTE project CIMA’; RTICC-RD06 00200061 and FIS PI10/02642.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Heptology
      Label-retaining liver cancer cells are relatively resistant to sorafenib
      Hong-Wu Xin Chenwi M Ambe Danielle M Hari Gordon W Wiegand Tyler C Miller Jin-Qiu Chen Andrew J Anderson Satyajit Ray John E Mullinax Tomotake Koizumi Russell C Langan Douglas Burka Michelle A Herrmann Paul K Goldsmith Alexander Stojadinovic Udo Rudloff Snorri S Thorgeirsson Itzhak Avital
      Gut 2013; 62 1777-1786 Published Online First: 14 Feb 2013. doi: 10.1136/gutjnl-2012-303261